NCOA2 and neoplasm: First, recurrent transposon insertions in SB-induced liver tumors resulted in decreased mRNA expression of Src-2 and one of its characterized targets G6pc. Second, inhibition of Src-2 using shRNAs promoted tumor formation by mouse hepatoblasts in immunocompromised mice.